Glaukos Corp (GKOS)
143.81
+2.98
(+2.12%)
USD |
NYSE |
Nov 22, 10:46
Glaukos Shareholders Equity (Quarterly): 668.51M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 668.51M |
| June 30, 2024 | 665.16M |
| March 31, 2024 | 450.73M |
| December 31, 2023 | 461.77M |
| September 30, 2023 | 477.66M |
| June 30, 2023 | 488.81M |
| March 31, 2023 | 508.51M |
| December 31, 2022 | 530.00M |
| September 30, 2022 | 548.55M |
| June 30, 2022 | 562.48M |
| March 31, 2022 | 597.56M |
| December 31, 2021 | 587.15M |
| September 30, 2021 | 601.05M |
| June 30, 2021 | 584.32M |
| March 31, 2021 | 589.77M |
| December 31, 2020 | 667.45M |
| September 30, 2020 | 661.56M |
| June 30, 2020 | 662.42M |
| March 31, 2020 | 641.30M |
| December 31, 2019 | 673.27M |
| Date | Value |
|---|---|
| September 30, 2019 | 190.12M |
| June 30, 2019 | 187.80M |
| March 31, 2019 | 185.49M |
| December 31, 2018 | 173.86M |
| September 30, 2018 | 163.41M |
| June 30, 2018 | 148.53M |
| March 31, 2018 | 143.03M |
| December 31, 2017 | 138.20M |
| September 30, 2017 | 132.10M |
| June 30, 2017 | 125.93M |
| March 31, 2017 | 122.95M |
| December 31, 2016 | 117.27M |
| September 30, 2016 | 110.20M |
| June 30, 2016 | 105.14M |
| March 31, 2016 | 98.06M |
| December 31, 2015 | 95.19M |
| September 30, 2015 | 94.77M |
| June 30, 2015 | 94.79M |
| March 31, 2015 | 6.135M |
| December 31, 2014 | -151.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
450.73M
Minimum
Mar 2024
673.27M
Maximum
Dec 2019
581.40M
Average
588.46M
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp | 20.71B |
| Baxter International Inc | 7.872B |
| Masimo Corp | 1.463B |
| Teleflex Inc | 4.482B |
| Perspective Therapeutics Inc | 328.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 926.54M |
| Total Liabilities (Quarterly) | 258.03M |
| Debt to Equity Ratio | 0.0849 |
| Current Ratio | 5.542 |
| Net Debt Paydown Yield | 0.63% |